Assignee
VLP THERAPEUTICS INC
US·4 granted patents·4 pending applications·0 citations·filing 2015–2025
Top patents by PatentIndex Score
8 records- 0176US2025129342A1Alphavirus replicon particleVLP THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0275US2024401081A1Cytokine immunotherapyVLP THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0371US12227770B2Alphavirus replicon particleVLP THERAPEUTICS INC·Filed 2021·Granted Feb 18, 2025·0 cites·14 claims
- 0468US12134777B2Alphavirus replicon vector and immunotherapy by administering sameVLP THERAPEUTICS INC·Filed 2021·Granted Nov 5, 2024·0 cites·17 claims
- 0567US2025228931A1Alphavirus replicon encoding chimeric sars-cov-2 receptor binding domainsVLP THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0666US12280102B2Alphavirus replicon encoding chimeric SARS-CoV-2 receptor binding domainsVLP THERAPEUTICS INC·Filed 2021·Granted Apr 22, 2025·0 cites·16 claims
- 0758US11345726B2Chikungunya virus (CHIKV) or Venezuelan equine encephalitis virus (VEEV) virus-like particles comprising heterologous antigens inserted into the envelope proteinVLP THERAPEUTICS INC·Filed 2015·Granted May 31, 2022·0 cites·13 claims
- 0858US2022347261A1Galectin-targeting immunotherapyVLP THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →